MeasuringU

MeasuringU is a UX research and software firm focused on connecting companies with their customers. We offer both quantitative and qualitative research support as well as access to our MUIQ testing platform. MUIQ is an advanced unmoderated remote testing tool that provides companies the ability to measure the user experience across all platforms. It contains the essential features and studies types to support agile testing of websites, prototypes, and mobile apps.

RadiaSoft LLC

RadiaSoft conducts $4M annually in contract R&D for a wide range of customers, including the federal government, national laboratories, universities and companies. Our core competencies include: 1) control system design and deployment for scientific and industrial facilities; 2) edge computing for real-time controls with complex models; 3) AI/ML for anomaly detection, controls and digital twins; 4) GUI development for science, engineering and controls; and 5) secure operation of cloud computing resources. Our differentiators include: 1) development of complex models involving multiple simulation codes; 2) world class software engineers and UI experts who work routinely with scientists; 3) collaboration with multiple national laboratories, including on-premises software deployment; and 4) algorithm development for heterogeneous computing, from supercomputers to FPGAs and other edge devices. RadiaSoft is developing Sirepo, a framework for browser-based GUIs that bring scientific computing to the cloud, https://www.sirepo.com

International Institute for Astronautical Sciences (IIAS)

The International Institute of Astronautical Sciences (IIAS) produces future scientists, engineers, operations professionals, and educators of the international space community through immersive educational experiences. Science and research produce peer-reviewed scientific publications, deployable space technologies, and inspires the next generation of space professionals.

keystone research corporation

SRA Trials LLC

Conduct, manage and supervise clinical trials phase I- IV.